US Bancorp DE Grows Stock Position in Axon Enterprise, Inc $AXON

US Bancorp DE increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 23.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 14,729 shares of the biotechnology company's stock after acquiring an additional 2,770 shares during the period. US Bancorp DE's holdings in Axon Enterprise were worth $12,195,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. TCTC Holdings LLC raised its holdings in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after buying an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC increased its holdings in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares during the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the first quarter valued at approximately $31,000. Catalyst Capital Advisors LLC acquired a new position in Axon Enterprise during the first quarter worth $32,000. Finally, Flaharty Asset Management LLC purchased a new position in shares of Axon Enterprise during the first quarter worth $33,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AXON. Piper Sandler initiated coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an "overweight" rating and a $893.00 price target on the stock. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the stock an "overweight" rating in a research report on Friday, July 11th. Zacks Research lowered Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, September 2nd. JMP Securities restated a "market outperform" rating and set a $825.00 target price on shares of Axon Enterprise in a research note on Monday, September 29th. Finally, Northland Securities set a $800.00 price target on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $841.64.

Insider Activity

In other news, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares of the company's stock, valued at $11,402,280. The trade was a 0.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $752.54, for a total value of $75,254.00. Following the completion of the sale, the director directly owned 1,416 shares in the company, valued at $1,065,596.64. This represents a 6.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold 59,932 shares of company stock worth $45,115,616 over the last quarter. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Down 4.2%

Shares of NASDAQ AXON opened at $703.03 on Friday. The stock has a market cap of $55.19 billion, a PE ratio of 173.59, a price-to-earnings-growth ratio of 27.30 and a beta of 1.41. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91. The business has a 50-day moving average price of $755.57 and a 200 day moving average price of $713.70. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the company earned $1.20 earnings per share. The company's revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.